Skip to menu Skip to content Skip to footer

2010

Conference Publication

Protease-activated receptor-2 and renal carcinogenesis

Vesey, D., Rajandram, R., Blakeney, J., Suen, J., Johnson, D., Fairlie, D. and Gobe, G. (2010). Protease-activated receptor-2 and renal carcinogenesis. 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth Convention and Exhibition Centre, Perth, Western Australia, 12-15 September 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2010.01377_1.x

Protease-activated receptor-2 and renal carcinogenesis

2010

Conference Publication

Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients

Barraclough, K. A., Campbell, S. B., Isbel, N. M., Johnson, D. W., Leary, D. R., Medley, G. and Staatz, C. E. (2010). Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients. XXIII International Congress of the Transplant Society, Vancouver Canada, 15-19 August 2010.

Prednisolone pharmacokinetics and sparse sampling strategies for monitoring in adult renal transplant recipients

2010

Conference Publication

Relapsing and recurrent peritoneal dialysis - associated peritonitis: Incidence, causes, predictors and outcomes

Burke, M., Hawley, C., Badve, S., McDonald, S., Brown, F., Rosman, J., Wiggins, K., Bannister, K. and Johnson, D. (2010). Relapsing and recurrent peritoneal dialysis - associated peritonitis: Incidence, causes, predictors and outcomes. 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth, Western Australia, 12‐15 September 2010. Hoboken, NJ United States: Wiley-Blackwell.

Relapsing and recurrent peritoneal dialysis - associated peritonitis: Incidence, causes, predictors and outcomes

2010

Conference Publication

The HMB-PP producing capacity of the causative pathogen and local gamma delta T cell numbers predict clinical outcome from bacterial peritonitis

Lin, C. Y., Roberts, G. W., Davey, M. S., Chess, J. A., Williams, J. D., Davies, S. J., Johnson, D. W., Moser, B. and Eberl, M. (2010). The HMB-PP producing capacity of the causative pathogen and local gamma delta T cell numbers predict clinical outcome from bacterial peritonitis. Annual Congress of the British Society for Immunology, Liverpool, United Kingdom, 6-10 December 2010. Oxford, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/j.1365-2567.2010.03390.x

The HMB-PP producing capacity of the causative pathogen and local gamma delta T cell numbers predict clinical outcome from bacterial peritonitis

2009

Journal Article

The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial

Petchey, William, Hickman, Ingrid J., Duncan, Emma, Prins, Johannes B., Hawley, Carmel M., Johnson, David W., Barraclough, Katherine and Isbel, Nicole M. (2009). The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial. BMC Nephrology, 10 (41) 41, x-x. doi: 10.1186/1471-2369-10-41

The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with Chronic Kidney Disease: a randomised controlled trial

2009

Journal Article

Reply

Barraclough, Katherine, Hawley, Carmel M., McDonald, Stephen .P, Brown, Fiona G., Rosman, Johan B., Wiggins, Kathryn J., Bannister, Kym .M and Johnson, David W. (2009). Reply. Nephrology Dialysis Transplantation, 24 (12), 3897-3898. doi: 10.1093/ndt/gfp466

Reply

2009

Journal Article

Prevention of access-related infection in dialysis

Barraclough, Katherine A., Hawley, Carmel M., Playford, E. Geoffrey and Johnson, David W. (2009). Prevention of access-related infection in dialysis. Expert Review of Anti-Infective Therapy, 7 (10), 1185-1200. doi: 10.1586/ERI.09.100

Prevention of access-related infection in dialysis

2009

Journal Article

Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor

Morais, Christudas, Gobe, Glenda, Johnson, David W. and Healy, Helen (2009). Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor. Angiogenesis, 12 (4), 365-379. doi: 10.1007/s10456-009-9158-0

Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor

2009

Journal Article

Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients

Badve, Sunil V., Smith, Alicia, Hawley, Carmel M. and Johnson, David W. (2009). Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients. Clinical Kidney Journal, 2 (6), 508-509. doi: 10.1093/ndtplus/sfp095

Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients

2009

Journal Article

Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations

Rumpsfeld, Markus, McDonald, Stephen P. and Johnson, David W. (2009). Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations. Peritoneal Dialysis International, 29 (6), 637-646. doi: 10.1177/089686080902900609

Peritoneal small solute clearance is nonlinearly related to patient survival in the Australian and New Zealand peritoneal dialysis patient populations

2009

Journal Article

Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma.

Morais, Christudas, Gobe, Glenda, Johnson, David W. and Healy, Helen (2009). Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma.. Apoptosis, 15 (4), 412-425. doi: 10.1007/s10495-009-0414-y

Inhibition of nuclear factor kappa B transcription activity drives a synergistic effect of pyrrolidine dithiocarbamate and cisplatin for treatment of renal cell carcinoma.

2009

Journal Article

Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David W., Prins, John B. and Isbel, Nicole M. (2009). Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study. BMC Nephrology, 10 (29) 29, xxx-xxx. doi: 10.1186/1471-2369-10-29

Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study

2009

Journal Article

Sevelamer versus calcium-based phosphate binders in chronic kidney disease: What should we conclude from the evidence to date

Johnson, David W. (2009). Sevelamer versus calcium-based phosphate binders in chronic kidney disease: What should we conclude from the evidence to date. Nephrology Dialysis Transplantation, 24 (10), 2970-2972. doi: 10.1093/ndt/gfp366

Sevelamer versus calcium-based phosphate binders in chronic kidney disease: What should we conclude from the evidence to date

2009

Journal Article

Recovery of renal function in end-stage renal failure – Comparison between peritoneal and haemodialysis

Macdonald, James A., McDonald, Stephen P., Hawley, Carmel M., Rosman, Johan, Brown, Fiona, Wiggins, Kathryn J., Bannister, Kym and Johnson, David W. (2009). Recovery of renal function in end-stage renal failure – Comparison between peritoneal and haemodialysis. Nephrology Dialysis Transplantation, 24 (9), 2825-2831. doi: 10.1093/ndt/gfp216

Recovery of renal function in end-stage renal failure – Comparison between peritoneal and haemodialysis

2009

Journal Article

Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infecTion in haemodialysis patients

Broom, Jennifer, O'Shea, Stacey, Govindarajula, Sridevi, Playford, Geoffrey, Hawley, Carmel M., Isbel, Nicole M., Campbell, Scott, Mudge, David, Carpenter, Sally, Johnson, Barbara, Underwood, Neil and Johnson, David W. (2009). Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infecTion in haemodialysis patients. BMC Nephrology, 10 (23) 23, xxx-xxx. doi: 10.1186/1471-2369-10-23

Rationale and design of the HEALTHY-CATH trial: A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of catheter associated infecTion in haemodialysis patients

2009

Journal Article

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

Barraclough, Katherine A., Noble, Euan, Leary, Diane, Brown, Fiona, Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Mudge, David, van Eps, Carolyn L., Sturtevant, Joanna M. and Johnson, David W. (2009). Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial). BMC Nephrology, 10 (1) 20, 20-1-20-7. doi: 10.1186/1471-2369-10-20

Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

2009

Journal Article

Higher Levels of Physical Activity Are Associated With a Lower Risk of Abnormal Glucose Tolerance in Renal Transplant Recipients

Orazio, Linda, Hickman, Ingrid, Armstrong, Kirsten, Johnson, David, Banks, Merrilyn and Isbel, Nicole (2009). Higher Levels of Physical Activity Are Associated With a Lower Risk of Abnormal Glucose Tolerance in Renal Transplant Recipients. Journal Of Renal Nutrition, 19 (4), 304-313. doi: 10.1053/j.jrn.2008.11.006

Higher Levels of Physical Activity Are Associated With a Lower Risk of Abnormal Glucose Tolerance in Renal Transplant Recipients

2009

Journal Article

Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases

O'Shea, Stacey, Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Rosman, Johan B., Wiggins, Kathryn J., Bannister, Kym M. and Johnson, David W. (2009). Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases. BMC Nephrology, 10 (1) 19, 19.1-19.9. doi: 10.1186/1471-2369-10-19

Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases

2009

Journal Article

To work or not to work? Child development and maternal labor supply

Frijters, Paul, Johnson, David W., Shah, Manisha and Shields, Michael A. (2009). To work or not to work? Child development and maternal labor supply. American Economic Journal: Applied Economics, 1 (3), 97-110. doi: 10.1257/app.1.3.97

To work or not to work? Child development and maternal labor supply

2009

Journal Article

Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination

Barraclough, Katherine A., Wiggins, Kathryn J, Hawley, Carmel M., van Eps, Carolyn L., Mudge, David W., Johnson, David W., Whitby, Michael, Carpenter, Sally and Playford, E. Geoffrey (2009). Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination. American Journal of Kidney Diseases, 54 (1), 95-103. doi: 10.1053/j.ajkd.2009.03.010

Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: A prospective open-label randomized controlled trial in nonresponders to primary vaccination